Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
2.740
+0.030 (1.11%)
Apr 16, 2026, 12:30 PM EDT - Market open
Indaptus Therapeutics Employees
Indaptus Therapeutics had 5 employees as of December 31, 2025. The number of employees decreased by 2 or -28.57% compared to the previous year.
Employees
5
Change (1Y)
-2
Growth (1Y)
-28.57%
Revenue / Employee
n/a
Profits / Employee
-$4,169,783
Market Cap
6.14M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | -2 | -28.57% | 5 | 0 |
| Dec 31, 2024 | 7 | 0 | - | 7 | 0 |
| Dec 31, 2023 | 7 | 1 | 16.67% | 7 | 0 |
| Dec 31, 2022 | 6 | 1 | 20.00% | 6 | 0 |
| Dec 31, 2021 | 5 | 3 | 150.00% | 5 | 0 |
| Jun 30, 2021 | 5 | - | - | 5 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 49 |
| KALA BIO | 38 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| BioRestorative Therapies | 14 |
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 10 |
| Immuron | 7 |
INDP News
- 3 months ago - Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - GlobeNewsWire
- 5 months ago - Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit - GlobeNewsWire
- 5 months ago - Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - Indaptus Therapeutics Provides Clinical Update - GlobeNewsWire
- 8 months ago - Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference - GlobeNewsWire
- 8 months ago - Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 10 months ago - Indaptus Therapeutics, Inc. Announces Additional Sale of $3.4 Million in Private Placement of Convertible Notes and Warrants - GlobeNewsWire
- 10 months ago - Indaptus Therapeutics Announces Reverse Stock Split - GlobeNewsWire